Analyst Louis Navellier has revised ratings for 195 major stocks, reflecting significant shifts in market sentiment. Key upgrades include MetLife, Inc. (MET) and Bristol-Myers Squibb Company (BMY), which both received ‘A’ grades across various assessments, highlighting improved performance metrics. The upgrades come amid increased institutional buying pressure and positive fundamental health indicators.
Conversely, Allstate Corporation (ALL) and Amgen Inc. (AMGN) faced downgrades to ‘B’ ratings, indicating a weakening of their previous strong positions. The entire evaluation based on quantitative and fundamental grades showcases crucial insights for investors looking to recalibrate their portfolios amid changing market dynamics.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
